Update on multi-drug resistant shigella

SHINE SA, 7/3/2019

The shigella outbreak is continuing in South Australia. This is to advise clinicians to be on alert for a potential increase in shigella cases, and to highlight updated recommendations on treatment as released by the Communicable Disease Control Branch (CDCB).

The outbreak is predominantly in men who have sex with men (MSM) and there is a potential for further increase in numbers related to a larger outbreak in Victoria and NSW. We encourage you to be alert for clients who have recently traveled interstate.The CDCB is now recommending that patients with confirmed multi-drug resistant (MDR) shigella (or at risk of MDR shigella while awaiting sensitivities) be treated with five days of Ceftrixaone 1g IV, rather than 1 day (as recommended in the Public Health Alert issued in December 2018).

HIV vaccine research: Adelaide team achieves ‘glimpse in right direction’

ABC News, 21.11.16

Progress toward vaccinating people against HIV infection has been announced by Adelaide researchers.

A team from the University of Adelaide and the Basil Hetzel Institute at Adelaide’s Queen Elizabeth Hospital used a combined vaccination approach, researcher Dr Branka Grubor-Bauk explained.

  • Read more here
  • Access article in Nature Scientific Reports (open access) here